Patents by Inventor Charito Buensuceso

Charito Buensuceso has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Decellularized pleural matrix
    Patent number: 9801910
    Abstract: The present invention pertains to the development of biologically derived extracellular matrices (ECM) derived from decellularized pleura tissue. Such matrices are useful in many clinical and therapeutic applications, including the repair, reconstruction, sealing, or joining of tissue, tendons, bones, and/or ligaments. In addition, the present invention features methods of making a biologically derived ECM derived from decellularized pleura tissue. The invention further features laminated ECM matrices.
    Type: Grant
    Filed: March 17, 2014
    Date of Patent: October 31, 2017
    Assignee: Ethicon, Inc.
    Inventors: Sridevi Dhanaraj, Chandra M. Valmikinathan, Charito Buensuceso, Agnieszka Seyda
  • Mammary artery derived cells and methods of use in tissue repair and regeneration
    Patent number: 9650611
    Abstract: An isolated mammalian internal mammary artery-derived cell is disclosed. Furthermore, methods of isolating the mammalian internal mammary artery-derived cell are disclosed. The cell is useful in tissue engineering technologies, specifically in vascular tissue engineering.
    Type: Grant
    Filed: November 8, 2012
    Date of Patent: May 16, 2017
    Assignee: DEPUY SYNTHES PRODUCTS, LLC
    Inventors: David C. Colter, Charito Buensuceso, Christian C. Kazanecki, Anna Gosiewska
  • DECELLULARIZED PLEURAL MATRIX
    Publication number: 20150258142
    Abstract: The present invention pertains to the development of biologically derived extracellular matrices (ECM) derived from decellularized pleura tissue. Such matrices are useful in many clinical and therapeutic applications, including the repair, reconstruction, sealing, or joining of tissue, tendons, bones, and/or ligaments. In addition, the present invention features methods of making a biologically derived ECM derived from decellularized pleura tissue. The invention further features laminated ECM matrices.
    Type: Application
    Filed: March 17, 2014
    Publication date: September 17, 2015
    Applicant: Ethion, Inc.
    Inventors: Sridevi Dhanaraj, Chandra M. Valmikinathan, Charito Buensuceso, Agnieszka Seyda
  • Mammary artery derived cells and methods of use in tissue repair and regeneration
    Patent number: 8889413
    Abstract: An isolated mammalian internal mammary artery-derived cell is disclosed. Furthermore, methods of isolating the mammalian internal mammary artery-derived cell are disclosed. The cell is useful in tissue engineering technologies, specifically in vascular tissue engineering.
    Type: Grant
    Filed: March 11, 2013
    Date of Patent: November 18, 2014
    Assignee: DePuy Synthes Products, LLC
    Inventors: David C. Colter, Charito Buensuceso, Christian C. Kazanecki, Anna Gosiewska
  • INDUCED PLURIPOTENT STEM CELLS FROM HUMAN UMBILICAL CORD TISSUE-DERIVED CELLS
    Publication number: 20140178989
    Abstract: We have disclosed an induced pluripotent stem cell and the method of preparing the induced pluripotent stem cell from a human umbilical cord tissue-derived cell. More particularly, we have disclosed a human umbilical cord tissue-derived iPS cell which may be differentiated into cells of ectoderm, mesoderm, and endoderm lineages.
    Type: Application
    Filed: November 21, 2013
    Publication date: June 26, 2014
    Inventors: Charito Buensuceso, Agineszka Seyda, David C. Colter, Sridevi Dhanaraj, Brian C. Kramer
  • INDUCED PLURIPOTENT STEM CELLS PREPARED FROM HUMAN KIDNEY-DERIVED CELLS
    Publication number: 20130157368
    Abstract: We have disclosed an induced pluripotent stem cell and the method of preparing the induced pluripotent stem cell from a human kidney-derived cell. More particularly, we have disclosed a human kidney-derived iPS cell which may be differentiated into cells of ectoderm, mesoderm, and endoderm lineages.
    Type: Application
    Filed: December 20, 2011
    Publication date: June 20, 2013
    Applicant: Advanced Technologies and Regenerative Medicine, LLC
    Inventors: Charito Buensuceso, Agnieszka Seyda, David C. Colter, Sridevi Dhanaraj, Brian C. Kramer, Jason Elliot Ekert, Amanda Lynn Kauffman
  • INDUCED PLURIPOTENT STEM CELLS FROM HUMAN UMBILICAL CORD TISSUE-DERIVED CELLS
    Publication number: 20130157365
    Abstract: We have disclosed an induced pluripotent stem cell and the method of preparing the induced pluripotent stem cell from a human umbilical cord tissue-derived cell. More particularly, we have disclosed a human umbilical cord tissue-derived iPS cell which may be differentiated into cells of ectoderm, mesoderm, and endoderm lineages.
    Type: Application
    Filed: December 20, 2011
    Publication date: June 20, 2013
    Applicant: Advanced Technologies and Regenerative Medicine, LLC
    Inventors: Charito Buensuceso, Agnieszka Seyda, David C. Colter, Sridevi Dhanaraj, Brian C. Kramer
  • Mammary artery derived cells and methods of use in tissue repair and regeneration
    Patent number: 8323972
    Abstract: An isolated mammalian internal mammary artery-derived cell is disclosed. Furthermore, methods of isolating the mammalian internal mammary artery-derived cell are disclosed. The cell is useful in tissue engineering technologies, specifically in vascular tissue engineering.
    Type: Grant
    Filed: September 20, 2010
    Date of Patent: December 4, 2012
    Assignee: Advanced Technologies and Regenerative Medicine, LLC
    Inventors: David C. Colter, Charito Buensuceso, Christian C. Kazanecki, Anna Gosiewska
  • FIBRIN BASED SCAFFOLD, PREPARATION AND USE THEREOF
    Publication number: 20120039855
    Abstract: The invention relates to a fibrin-based scaffold suitable for supporting a population of cells comprising mesenchymal stem cells (MSC) and/or umbilical tissue derived cells (UTC) at the site of administration for a prolonged period of time. The scaffold is capable of supporting at least 1×106 cells/ml scaffold. The invention also relates to the preparation of the scaffold and to its use. Preparation of the scaffold is carried out with a fibrinogen component comprising fibrinogen having a final concentration of higher than 17.5 mg/ml scaffold. The scaffold and the embedded MSC and/or UTC can be used for increasing vascularization and/or wound healing at the site of administration.
    Type: Application
    Filed: August 10, 2011
    Publication date: February 16, 2012
    Inventors: Roee Atlas, Israel Nur, Roberto Meidler, Liliana Bar, Charito Buensuceso, Anthony J. Kihm, Sridevi Dhanaraj
  • MAMMARY ARTERY DERIVED CELLS AND METHODS OF USE IN TISSUE REPAIR AND REGENERATION
    Publication number: 20110076769
    Abstract: An isolated mammalian internal mammary artery-derived cell is disclosed. Furthermore, methods of isolating the mammalian internal mammary artery-derived cell are disclosed. The cell is useful in tissue engineering technologies, specifically in vascular tissue engineering.
    Type: Application
    Filed: September 20, 2010
    Publication date: March 31, 2011
    Applicant: Advanced Technologies and Regenerative Medicine, LLC
    Inventors: David C. Colter, Charito Buensuceso, Christian C. Kazanecki, Anna Gosiewska
  • Tissue engineering devices for the repair and regeneration of tissue
    Publication number: 20060153815
    Abstract: Tissue engineering devices for use in the repair or regeneration of tissue made of support scaffolds and cell sheets.
    Type: Application
    Filed: December 15, 2005
    Publication date: July 13, 2006
    Inventors: Agnieszka Seyda, David Colter, Charito Buensuceso, Sridevi Dhanaraj, Anna Gosiewska, Jeffrey Geesin, Angelo Scopelianos